Cicardi M, Frangi D, Bergamaschini L, Gardinali M, Sacchi G, Agostoni A
Complement. 1985;2(2-3):133-9. doi: 10.1159/000467853.
A patient with echinococcosis, acquired deficiency of the inhibitor of the activated first component of complement and angioedema symptoms has been studied. These symptoms started 7 months after the surgical removal of an echinococcus liver cyst. Eight years later, when the complement was investigated, a marked deficiency of the C1 inhibitor, C1, C4 and CH50 was present. The patient was therefore successfully treated with tranexamic acid. After 4 years, the woman needed another operation because of a relapse of echinococcosis; afterwards she was symptom-free without medications, while the complement profile remained unchanged. Circulating immune complexes were detected by the conglutinin method. The patient's serum was demonstrated to possess an anticomplementary activity without affecting the C1 inhibitor when incubated with normal human serum at 37 degrees C. At present, 16 years after the onset of the symptoms, there are no signs of lymphoproliferative disease.
对一名患有棘球蚴病、获得性补体激活第一成分抑制剂缺乏症并伴有血管性水肿症状的患者进行了研究。这些症状在手术切除肝棘球蚴囊肿7个月后开始出现。8年后,当对补体进行检测时,发现C1抑制剂、C1、C4和CH50明显缺乏。因此,该患者成功接受了氨甲环酸治疗。4年后,该女性因棘球蚴病复发需要再次手术;术后她无需药物治疗即无症状,而补体谱保持不变。采用胶固素方法检测循环免疫复合物。当患者血清在37℃与正常人血清孵育时,显示具有抗补体活性,但不影响C1抑制剂。目前,症状出现16年后,没有淋巴增殖性疾病的迹象。